As both AST and ALT are readily available and are easily measurable biomarkers in daily clinical practice, early identification of those at a high risk of frailty among older patients with heart failure may lead to early intervention, including nutritional intervention or exercise rehabilitation, and subsequently, a better prognosis. The gene discussed is GPT; the disease is heart failure.